Lovafarma SRL
The score of Lovafarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +584 % Total assets +305 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lovafarma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 411,577 € | ||||
| Equity | 903,035 € | ||||
| Cash | 261,639 € | ||||
| EBITDA | 676,720 € | ||||
| Total assets | €1.60m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Sep 2026
- Year ended 31 Dec 2024filed on 08 Aug 2025
- Year ended 31 Dec 2023filed on 29 Sep 2024
- Year ended 31 Dec 2022filed on 22 Aug 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
Lovafarma's financial analysis
- Solvency56.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lovafarma
Lovafarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.540.511
- VAT number
- BE0476540511
- Peppol
- Registered · 0208:0476540511 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jan 2002
- Registered office
- 3010 Leuven
- Latest accounts
- 2025 · filed on 03 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lovafarma (SRL) has been based in Leuven since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 411,577 € and equity of 903,035 €; its revenue is not published. Its solvency stands at 56.3%, above the median of its sector (44.2%).
Companies similar to Lovafarma
Companies in the same business, of comparable size and area, outside its group.
- DE-Pharma Retail sale of pharmaceutical products Mons · balance sheet €1.60m
- Dekerk Kumtich Retail sale of pharmaceutical products Tienen · balance sheet €1.60m
- Apotheek Cauwerburg Retail sale of pharmaceutical products Temse · balance sheet €1.61m
- Monin-Donnez Retail sale of pharmaceutical products Momignies · balance sheet €1.61m
- Pharmacies et Gestion de Pharmacies Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €1.61m
- Pharmacie Hasey-De Coninck Retail sale of pharmaceutical products Beaumont · balance sheet €1.62m
- Ciel Pharma Retail sale of pharmaceutical products Brussels · balance sheet €1.62m
- Liephar Retail sale of pharmaceutical products Mettet · balance sheet €1.59m
Frequently asked questions about Lovafarma
What is the revenue of Lovafarma?
Lovafarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lovafarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0476540511 for Lovafarma, if the company is VAT-registered. Its company number (CBE) is 0476.540.511.
Where is the registered office of Lovafarma?
According to the CBE register, the registered office of Lovafarma is in 3010 Leuven.
What is the equity of Lovafarma?
At the close of the 2025 financial year, the equity of Lovafarma amounts to 903,035 €, a solvency of 56.3% of total assets.
Who manages Lovafarma?
The register lists 2 active mandates at Lovafarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lovafarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →